Table of Contents

2019-2024 Global Inhalation Therapy Nebulizer Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Inhalation Therapy Nebulizer Consumption 2014-2024
  • 2.1.2 Inhalation Therapy Nebulizer Consumption CAGR by Region
• 2.2 Inhalation Therapy Nebulizer Segment by Type
  • 2.2.1 Pneumatic Nebulizers
  • 2.2.2 Ultrasonic Nebulizers
  • 2.2.3 Mesh Nebulizers
• 2.3 Inhalation Therapy Nebulizer Consumption by Type
  • 2.3.1 Global Inhalation Therapy Nebulizer Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Inhalation Therapy Nebulizer Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Inhalation Therapy Nebulizer Sale Price by Type (2014-2019)
• 2.4 Inhalation Therapy Nebulizer Segment by Application
  • 2.4.1 COPD
  • 2.4.2 Cystic Fibrosis
  • 2.4.3 Asthma
  • 2.4.4 Other
• 2.5 Inhalation Therapy Nebulizer Consumption by Application
  • 2.5.1 Global Inhalation Therapy Nebulizer Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Inhalation Therapy Nebulizer Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Inhalation Therapy Nebulizer Sale Price by Application (2014-2019)

3 Global Inhalation Therapy Nebulizer by Players

• 3.1 Global Inhalation Therapy Nebulizer Sales Market Share by Players
  • 3.1.1 Global Inhalation Therapy Nebulizer Sales by Players (2017-2019)
  • 3.1.2 Global Inhalation Therapy Nebulizer Sales Market Share by Players (2017-2019)
• 3.2 Global Inhalation Therapy Nebulizer Revenue Market Share by Players
  • 3.2.1 Global Inhalation Therapy Nebulizer Revenue by Players (2017-2019)
  • 3.2.2 Global Inhalation Therapy Nebulizer Revenue Market Share by Players (2017-2019)
• 3.3 Global Inhalation Therapy Nebulizer Sale Price by Players
• 3.4 Global Inhalation Therapy Nebulizer Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Inhalation Therapy Nebulizer Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Inhalation Therapy Nebulizer Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Inhalation Therapy Nebulizer by Regions

• 4.1 Inhalation Therapy Nebulizer by Regions
  • 4.1.1 Global Inhalation Therapy Nebulizer Consumption by Regions
  • 4.1.2 Global Inhalation Therapy Nebulizer Value by Regions
• 4.2 Americas Inhalation Therapy Nebulizer Consumption Growth
• 4.3 APAC Inhalation Therapy Nebulizer Consumption Growth
• 4.4 Europe Inhalation Therapy Nebulizer Consumption Growth
• 4.5 Middle East & Africa Inhalation Therapy Nebulizer Consumption Growth

5 Americas

• 5.1 Americas Inhalation Therapy Nebulizer Consumption by Countries
  • 5.1.1 Americas Inhalation Therapy Nebulizer Consumption by Countries (2014-2019)
  • 5.1.2 Americas Inhalation Therapy Nebulizer Value by Countries (2014-2019)
• 5.2 Americas Inhalation Therapy Nebulizer Consumption by Type
• 5.3 Americas Inhalation Therapy Nebulizer Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Inhalation Therapy Nebulizer Consumption by Countries
  • 6.1.1 APAC Inhalation Therapy Nebulizer Consumption by Countries (2014-2019)
  • 6.1.2 APAC Inhalation Therapy Nebulizer Value by Countries (2014-2019)
• 6.2 APAC Inhalation Therapy Nebulizer Consumption by Type
• 6.3 APAC Inhalation Therapy Nebulizer Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Inhalation Therapy Nebulizer by Countries
  • 7.1.1 Europe Inhalation Therapy Nebulizer Consumption by Countries (2014-2019)
  • 7.1.2 Europe Inhalation Therapy Nebulizer Value by Countries (2014-2019)
• 7.2 Europe Inhalation Therapy Nebulizer Consumption by Type
• 7.3 Europe Inhalation Therapy Nebulizer Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Inhalation Therapy Nebulizer by Countries
  • 8.1.1 Middle East & Africa Inhalation Therapy Nebulizer Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Inhalation Therapy Nebulizer Value by Countries (2014-2019)
• 8.2 Middle East & Africa Inhalation Therapy Nebulizer Consumption by Type
• 8.3 Middle East & Africa Inhalation Therapy Nebulizer Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Inhalation Therapy Nebulizer Distributors
• 10.3 Inhalation Therapy Nebulizer Customer

11 Global Inhalation Therapy Nebulizer Market Forecast

• 11.1 Global Inhalation Therapy Nebulizer Consumption Forecast (2019-2024)
• 11.2 Global Inhalation Therapy Nebulizer Forecast by Regions
  • 11.2.1 Global Inhalation Therapy Nebulizer Forecast by Regions (2019-2024)
  • 11.2.2 Global Inhalation Therapy Nebulizer Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Inhalation Therapy Nebulizer Forecast by Type
• 11.8 Global Inhalation Therapy Nebulizer Forecast by Application

12 Key Players Analysis

• 12.1 PARI GmbH
  • 12.1.1 Company Details
  • 12.1.2 Inhalation Therapy Nebulizer Product Offered
  • 12.1.3 PARI GmbH Inhalation Therapy Nebulizer Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 PARI GmbH News
• 12.2 Omron
  • 12.2.1 Company Details
  • 12.2.2 Inhalation Therapy Nebulizer Product Offered
  • 12.2.3 Omron Inhalation Therapy Nebulizer Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Omron News
• 12.3 Drive DeVilbiss Healthcare
  • 12.3.1 Company Details
  • 12.3.2 Inhalation Therapy Nebulizer Product Offered
  • 12.3.3 Drive DeVilbiss Healthcare Inhalation Therapy Nebulizer Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Drive DeVilbiss Healthcare News
• 12.4 Philips Respironics
  • 12.4.1 Company Details
  • 12.4.2 Inhalation Therapy Nebulizer Product Offered
  • 12.4.3 Philips Respironics Inhalation Therapy Nebulizer Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Philips Respironics News
• 12.5 Yuwell
  • 12.5.1 Company Details
  • 12.5.2 Inhalation Therapy Nebulizer Product Offered
  • 12.5.3 Yuwell Inhalation Therapy Nebulizer Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Yuwell News
• 12.6 Leyi
  • 12.6.1 Company Details
  • 12.6.2 Inhalation Therapy Nebulizer Product Offered
  • 12.6.3 Leyi Inhalation Therapy Nebulizer Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Leyi News
• 12.7 Folee
  • 12.7.1 Company Details
  • 12.7.2 Inhalation Therapy Nebulizer Product Offered
  • 12.7.3 Folee Inhalation Therapy Nebulizer Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Folee News
• 12.8 Medel S.p.A
  • 12.8.1 Company Details
  • 12.8.2 Inhalation Therapy Nebulizer Product Offered
  • 12.8.3 Medel S.p.A Inhalation Therapy Nebulizer Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Medel S.p.A News
• 12.9 Briggs Healthcare
  • 12.9.1 Company Details
  • 12.9.2 Inhalation Therapy Nebulizer Product Offered
  • 12.9.3 Briggs Healthcare Inhalation Therapy Nebulizer Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Briggs Healthcare News
• 12.10 3A Health Care
  • 12.10.1 Company Details
  • 12.10.2 Inhalation Therapy Nebulizer Product Offered
  • 12.10.3 3A Health Care Inhalation Therapy Nebulizer Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 3A Health Care News
• 12.11 Trudell Medical International
• 12.12 GF Health Products

13 Research Findings and Conclusion

A nebulizer changes medication from a liquid to a mist so that it can be more easily inhaled into the lungs. Nebulizers are particularly effective in delivering asthma medications to infants and small children and to anyone who has difficulty using an asthma inhaler.
The global average price of Inhalation Therapy Nebulizer is in the decreasing trend, from 64.9 USD/Unit in 2012 to 61.0 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Inhalation Therapy Nebulizer includes Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers, and the proportion of Pneumatic Nebulizers in 2016 is about 56%.

Inhalation Therapy Nebulizer is widely used for the treatment of COPD, Cystic Fibrosis, Asthma and other respiratory disorders. The most proportion of Inhalation Therapy Nebulizer is used to treat Asthma, and the proportion in 2016 is 53%.

North America is the largest supplier of Inhalation Therapy Nebulizer, with a production market share nearly 29% in 2016. Japan is the second largest supplier of Inhalation Therapy Nebulizer Media, enjoying production market share nearly 22% in 2016.

North America is the largest consumption place, with a consumption market share nearly 39% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 32%.

Market competition is not intense. PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

According to this study, over the next five years the Inhalation Therapy Nebulizer market will register a 6.5% CAGR in terms of revenue, the global market size will reach US$ 1270 million by 2024, from US$ 870 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Inhalation Therapy Nebulizer business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Inhalation Therapy Nebulizer market by product type, application, key manufacturers and key regions and countries.

This study considers the Inhalation Therapy Nebulizer value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Pneumatic Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
COPD
Cystic Fibrosis
Asthma
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
PARI GmbH
Omron
Drive DeVilbiss Healthcare
Philips Respironics
Yuwell
Leyi
Folee
Medel S.p.A
Briggs Healthcare
3A Health Care
Trudell Medical International
GF Health Products

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Inhalation Therapy Nebulizer consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Inhalation Therapy Nebulizer market by identifying its various subsegments.
Focuses on the key global Inhalation Therapy Nebulizer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Inhalation Therapy Nebulizer with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Inhalation Therapy Nebulizer submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.